Myozyme Articles
Genzyme to invest 250 million euros for Belgian plant to support growth of Myozyme and Lumizyme
21 January 2011
Good news at last for Genzyme, which gets FDA approval for Lumizyme earlier than anticipated
26 May 2010
US FDA to take enforcement action regarding Genzyme’s Allston plant, including financial penalties
25 March 2010
Genzyme’s 4th quarter 2009 earnings plunge due to manufacturing problems for two leading products; expands research in Europe
18 February 2010
More bad news for Genzyme as US FDA delays Lumizyme application
17 November 2009
FDA finds trash particles in Genzyme’s drugs, leading firm to advise health care providers
16 November 2009
Third-quarter 2009 profit sinks at Genzyme, on production woes
22 October 2009
Genzyme warned plant does not meet cGMP
23 March 2009
US approval of Genzyme
9 March 2009
FDA approves Genzyme's Geel Myozyme facility
9 March 2009
Stock Commentary - New York week to Mar 2, 2009
9 March 2009
Positive opinion on Genzyme's Myozyme
2 March 2009
Genzyme's 2008 profit down on costs
23 February 2009
EMEA prioriatizes Myozyme access
26 January 2009
Stock Commentary - New York week to Dec 1, 2008
8 December 2008
Acelerated appro for Myozyme produced at the 2000 L Bioreactor Scale
24 November 2008
Genzyme's 3rd-qtr 2008 profit down 25%
3 November 2008
Genzyme announces global R&D expansion
29 September 2008
Genzyme's 2nd qtr profit hit by license cost
4 August 2008
Stock Commentary - New York week to July 14, 2008
21 July 2008
Genzyme's 1st-qtr revenues jump 25%
5 May 2008
Genzyme's 4th-qtr 2007 revenue jumps 21%
25 February 2008
Strong third quarter for Genzyme: GAAP net income reaches $159M on the back of good sales
5 November 2007
Genzyme settles law suit for $64 million
20 August 2007
Stock Commentary - New York week to Aug 13, 2007
20 August 2007
Genzyme's 2nd-qtr net income jumps 4%
6 August 2007
Genzyme's 1st-qtr net income soars 57%
7 May 2007
Genzyme sees 4th-qtr loss on AnorMED buy
26 February 2007
US FDA approves Genzyme's Myozyme
8 May 2006
Genzyme's 1st-qtr sales less than expected
1 May 2006
Genzyme's Myozyme gets EU go-ahead
10 April 2006
Genzyyme submits BLA for Myozyme
8 August 2005
Genzyme $57.3M net loss for 4th qtr 2004
28 February 2005
Myzozyme MAA lifts Genzyme
10 January 2005
Italy seeks US aid over Pompe disease
30 June 2003
Genzyme's Myozyme begins Pompe study
9 June 2003
Genzyme starts Pompe disease trials
31 March 2003
4th-qtr charges hit Genzyme General
17 March 2003
Showing 1-43 of 43 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
